Generic placeholder image

Current Pharmacogenomics

Editor-in-Chief

ISSN (Print): 1570-1603
ISSN (Online): 1570-1603

Apoptosis in Drug Response

Author(s): Simone Fulda and Klaus-Michael Debatin

Volume 1, Issue 1, 2003

Page: [9 - 16] Pages: 8

DOI: 10.2174/1570160033378358

Open Access Journals Promotions 2
conference banner
Abstract

Apoptosis, the cells intrinsic death program, plays an important role in the regulation of tissue homeostasis. Imbalances between cell death and survival may result in premature death, uncontrolled proliferation or tumor formation. Also, killing of cancer cells by various cytotoxic approaches such as anticancer drugs, γ-irradiation, suicide genes or immunotherapy, is predominantly mediated through induction of apoptosis in target cells. Thus, defects in apoptosis programs that suppress cell death can also confer drug resistance. Understanding the molecular events that regulate apoptosis and how tumor cells evade apoptotic deletion have provided a paradigm to link cancer genetics and response to cancer therapy. Insights into the signaling cascades that regulate drug-induced apoptosis provide rational targets for therapeutic interventions. Also, genetic variability in apoptosis regulatory genes found in tumors of individual patients may contribute to variability in drug response. Thus, monitoring expression profiles of apoptosis genes in tumors of individual patients or in response to specific pharmacological agents may serve as predictive markers of drug response.

Keywords: apoptosis, drug response, intrinsic death program, tissue homeostasis, suicide genes


© 2024 Bentham Science Publishers | Privacy Policy